publication . Article . 2011

Risk of potentially life-threatening thyroid dysfunction due to amiodarone in idiopathic pulmonary arterial hypertension patients.

Soon, Elaine; Toshner, Mark; Mela, Marianna; Grace, Andrew; Sheares, Karen; Morrell, Nicholas; Pepke-Zaba, Joanna;
  • Published: 01 Feb 2011 Journal: Journal of the American College of Cardiology, volume 57, pages 997-998 (issn: 0735-1097, Copyright policy)
  • Publisher: Elsevier BV
To the Editor: Amiodarone is used as an antiarrhythmic agent in patients with pulmonary hypertension, who suffer the double insult of having an increased susceptibility to arrhythmias as well as being more likely to suffer cardiovascular compromise as a result of these arrhythmias ([1][1]). Other
Medical Subject Headings: cardiovascular diseasescardiovascular system
free text keywords: Cardiology and Cardiovascular Medicine, Diabetes mellitus, medicine.disease, medicine, Thyroid dysfunction, Pulmonary hypertension, Cardiology, medicine.medical_specialty, Idiopathic Pulmonary Arterial Hypertension, Antiarrhythmic agent, medicine.medical_treatment, Amiodarone, medicine.drug, business.industry, business, Internal medicine, thyroid
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue